-
Mashup Score: 4Rosuvastatin vs. Atorvastatin Treatment in Patients With Coronary Artery Disease - American College of Cardiology - 8 month(s) ago
Anthony A. Bavry, M.D., M.P.H., FACC
Source: www.acc.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Cardiac CT before TAVR detects CAD with high accuracy, suggesting a reduced need for invasive imaging - 8 month(s) ago
New research from a team of specialists at Cleveland Clinic included data from more than 2,000 TAVR patients.
Source: cardiovascularbusiness.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
CTA is effective for ruling out proximal #cvCAD before patients undergo #TAVR, according to a new study in #JACCINT. Read more about the findings in @CardioBusiness: https://t.co/gpDPaHUqfE
-
-
Mashup Score: 3MULTISTARS AMI: Immediate vs. Staged Multivessel PCI in STEMI Patients - American College of Cardiology - 8 month(s) ago
Immediate multivessel PCI was non-inferior to staged multivessel PCI for reducing death and ischemic events in patients with STEMI and multivessel coronary artery disease, according to results from the MULTISTARS AMI trial presented at ESC Congress 2023. Researchers randomized 840 patients with acute STEMI and multivessel coronary artery disease from 37 sites in Europe to either immediate PCI or staged PCI of non-culprit lesions within 19-45 days. The average age of participants as 65 years and approximate
Source: www.acc.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Results from MULTISTARS AMI trial find immediate multivessel #PCI is non-inferior to staged multivessel PCI for reducing death and ischemic events in #STEMI patients and multivessel coronary artery disease. Learn more: https://t.co/cgWIevd3Hb #ESCCongress #cvCAD https://t.co/Es3QCRyIRJ
-
-
Mashup Score: 10
The biggest unknown is whether this would increase the likelihood of more allograft vasculopathy down the line.
Source: www.tctmd.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
According to a new study in #JACC, donor-transmitted #cvCAD after #Hearttx could occur in 1/5 of patients but doesn’t appear to affect survival in patients who are able to undergo angiography within 3 months post-transplant. https://t.co/yl4tCdgYmW @TCTMD @TCTMD_Yael
-
-
Mashup Score: 2PRECISE Data Validate Deferral of CAD Testing for Low-Risk Patients - 8 month(s) ago
Guideline recommendation had been based on assumptions
Source: www.medpagetoday.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
The PRECISE trial found that deferred testing for suspected #cvCAD in patients w/ low risk scores was safe & led to less unnecessary catheterizations. @cphend reports on the findings in @medpagetoday: https://t.co/dVI06fc9Dj #CardioTwitter
-
-
Mashup Score: 2
Welcome to JACC Edge, a monthly newsletter highlighting hot topics published across the family of JACC Journals. Your browser does not support the audio
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet-
A new issue of #JACCEdge is out! This month's issue features Chronic Coronary Disease: Move Aside AMI Read the issue 👉 https://t.co/YP8QBy7nhc #cvCAD #CTO #cvCoag #ChronicCoronaryDisease #CardioEd #CardioTwitter @PratikDoshiMD https://t.co/V3so1o3Dl3
-
-
Mashup Score: 1Coronary Disease That Comes With a Donor Heart Does Carry Risk - 8 month(s) ago
Study shows cardiovascular consequences but not overall mortality impact
Source: www.medpagetoday.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#cvCAD that comes w/ a donor ❤️ was not uncommon & conferred CV risk, according to new research in #JACC. https://t.co/uV05XiK6qr @medpagetoday @cphend
-
-
Mashup Score: 21Prevalence, Characteristics, and Prognostic Relevance of Donor-Transmitted Coronary Artery Disease in Heart Transplant Recipients: - 8 month(s) ago
Abstract Background The reported prevalence of donor-transmitted coronary artery disease (TCAD) in heart transplantation (HT) is variable, and its prognostic impact remains unclear. Objectives The …
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet-
Overall survival after a heart transplant isn’t negatively affected by donor’s CAD, but those patients have higher CV mortality and worse CV outcomes: https://t.co/6eiRMWsq9e #JACC #cvCAD #HeartTx #CardioTwitter @david_cm_ @eduardo_barge https://t.co/9VidXR6S5i
-
-
Mashup Score: 2Study Concludes CAD Transmitted from Donor a Risk Factor for CV Death and MACE in Heart Transplant Patients - 8 month(s) ago
Significant transmitted coronary artery disease (s-TCAD) is an independent risk factor for cardiovascular death and nonfatal major adverse cardiovascular events (MACE) in patients undergoing a heart t
Source: www.crtonline.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
According to a new study in #JACC, s-TCAD is an independent risk factor for CV death & nonfatal MACE in patients undergoing a #Hearttx. https://t.co/9wea4RmWzw @CRT_meeting #cvCAD
-
-
Mashup Score: 6Primary Percutaneous Coronary Intervention in Patients With Spontaneous Coronary Artery Dissection vs Coronary Artery Disease: - 8 month(s) ago
Abstract Background Spontaneous coronary artery dissection (SCAD) is a rare cause of acute myocardial infarction. Revascularization in SCAD remains very challenging and therefore is not recommended…
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet-
🔬 New #JACCINT study alert! #SCAD vs #CAD in #STEMI: 🏥👩⚕️ SCAD PPCI is on par w/ non-SCAD PPCI: 🫀in-hospital death (5.7% vs 4.8%) 🫀30-day readmission (3% vs 3.3%) 📎 https://t.co/SOc52YNtbT #CardioTwitter #PCI #cvCAD @FJ_Elola https://t.co/GNsrELZoJL
-
The goal of the LODESTAR trial was to evaluate rosuvastatin compared with atorvastatin among patients with coronary artery disease. The trial was presented during #ESCCongress. Read the full details here: https://t.co/TWdY1s3NQP #cvCAD